Tatyana Ivanovna Vlasova

Tatyana Ivanovna Vlasova

Auto-generated profile, based on publicly available information

Tatyana Ivanovna Vlasova


Research Focus & Metrics

Academic Career Length

10Years (2017-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
1 January 2021 in University proceedings. Volga region. Medical sciences
Verified
Journal Article
Closed access
TVT.I. Vlasova
T.I. Vlasova
OUOgarev Mordovia State University
Ogarev Mordovia State University
MSM.A. Spirina
M.A. Spirina
EAE.V. Arsent'Eva
E.V. Arsent'Eva
ESE.A. Shamrova
E.A. Shamrova
ASA.V. Sitdikova
A.V. Sitdikova
Article 11421. Пензенский государственный университет

27 January 2021 in The Egyptian Journal of Bronchology
Verified
Journal Article
Open access
PDF file
Basheer Abdullah MarzoogBasheer Abdullah Marzoog
Basheer Abdullah Marzoog
TVTatyana Ivanovna Vlasova
Tatyana Ivanovna Vlasova
Background: The paper aimed to analyze and evaluate the present literature data on the clinical effectiveness of using the bacillus Calmette–Guérin (BCG) vaccine in protecting against the novel coronavirus disease 2019 (COVID-19). Main body: Several novel clinical data have shown a relationship between the vaccinated population with the bacillus Calmette–Guérin (BCG) vaccine and the severity and mortality rate from coronavirus disease 2019 (COVID-19). However, the linkage between the BCG vaccine and COVID-19 infection mortality and morbidity rate is still ambiguous. The BCG has been protected previously from many other respiratory viral infections. The efficacy of the BCG vaccine in the protection against COVID-19 depends on various factors including social, economic, cultural norms, mitigation efforts, health infrastructure, and demographic differences between countries. Conclusion: Thus, the literature analyses show a noticed difference between the countries that follow national vaccination programs than in countries that do not follow such programs (Italy, Netherlands, USA). However, there are not any recommendations for using BCG in the protection against severe cases of COVID-19. The severity of COVID-19 maybe depends on the age, immune state of the patient, and the level of vaccine coverage. The possible reason for BCG protection is trained immunity in both diseases.

1 January 2017 in University proceedings. Volga region. Medical sciences
Verified
Journal Article
Closed access
OUOgarev Mordovia State University
Ogarev Mordovia State University
AVA. P. Vlasov
A. P. Vlasov
TVT. I. Vlasova
T. I. Vlasova
TMT. A. Muratova
T. A. Muratova
SASh. S. Al'-Kubaysi
Sh. S. Al'-Kubaysi
OKO. V. Kirdyashkina
O. V. Kirdyashkina
Статья 1117. Пензенский государственный университет

1 January 2021 in University proceedings. Volga region. Medical sciences
Verified
Journal Article
Closed access
OUOgarev Mordovia State University
Ogarev Mordovia State University
TVT.I. Vlasova
T.I. Vlasova
EAE.V. Arsent'EVa
E.V. Arsent'EVa
Basheer Abdullah MarzoogBasheer Abdullah Marzoog
Basheer Abdullah Marzoog
Article 14321. Пензенский государственный университет

1 January 2022 in University proceedings. Volga region. Medical sciences
Verified
Journal Article
Closed access
TVT.I. Vlasova
T.I. Vlasova
OUOgarev Mordovia State University
Ogarev Mordovia State University
VTV.A. Trofimov
V.A. Trofimov
EAE.V. Arsent'Eva
E.V. Arsent'Eva
ASA.V. Sitdikova
A.V. Sitdikova
TST.I. Shishkanova
T.I. Shishkanova
Article 16222. Пензенский государственный университет

11 April 2025 in Doklady Biological Sciences
Verified
Journal Article
Closed access
PDF file
TVT. I. Vlasova
T. I. Vlasova
EBE. P. Brodovskaya
E. P. Brodovskaya
KMK. S. Madonov
K. S. Madonov
VAV. P. Ageev
V. P. Ageev
AAA. P. Abelova
A. P. Abelova
AVA. P. Vlasov
A. P. Vlasov
The regenerative potential of platelet-rich plasma (PRP) samples from patients with type 1 diabetes mellitus (DM) was studied in vitro. In a series of experiments, PRP was added to the culture medium of human dermal fibroblasts. The cells were tested for metabolic (including reactive oxygen species production), migration, and proliferative activities at several time points; growth factors and exosome levels were assessed in PRP and the medium. A lower proliferative effect, pro-oxidant properties, and toxicity were observed for PRPs from diabetic patients. Namely, treated fibroblasts showed lower metabolic activity, a lower cell viability, and a greater percentage of necrosis in culture, while their migration properties were not impaired. PRPs from diabetic patients exerted a lower stimulatory effect on growth factor secretion by dermal fibroblasts. PRPs from elderly diabetics had the greatest effects.